Columnistas Expertos

Dermot Cox
Columnista Experto de SIIC

Dept. Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublín, Irlanda

Artículos publicados (selección):

NUEVAS NOCIONES ACERCA DE LOS ANTAGONISTAS DE LOS RECEPTORES GPIIB/GPIIIA
Columnista Experto de SIIC Dermot Cox en colaboración con

Primera edición en siicsalud: 19 de septiembre, 2003
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/20051
Especialidad principal: Farmacología

Especialidades relacionadas:

Cardiología,

Medicina Farmacéutica,

Medicina Interna,

Helicobacter pylori interacts with GPIb to induce platelet aggregation, Gastroenterology :

Characterization of a ligand-attenuated binding site on glycoprotein IIb/IIIa, Thrombosis & Haemostasis 88(88):811-816, 2002

A role for Glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation, Blood 100:509-516, 2002

Staphylococcus aureus-induced platelet aggregation involves clumping factors A and B and the serine-aspartate repeat protein E., Molecular Microbiology 44(44):1033-1044, 2002

Glycoprotein IIb/IIIa receptor number and occupancy during chronic administration of an oral antagonist, Journal Pharmacology Experimental Therapeutics 295(295):670-676, 2000

Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes, Journal American College of Cardiology 36(36):1514-1519, 2000

Quantifying GPIIb/IIIa receptor binding using two monoclonal antibodies. Discriminating abciximab and small molecular weight antagonists, Circulation 99(99):, 1999

Dermot Cox

ua40317